Antimicrobial resistance (AMR) has been called the silent pandemic. FasterCures seeks to encourage the development of new antibiotics by promoting policies that could incentivize drug developers, investigate ways to bring more private capital into the space, and highlight emerging approaches to treating bacterial infections beyond antibiotics.
Despite unprecedented advances in medical science that enabled the development of novel COVID-19 vaccines and therapies at record speed, the COVID-19 pandemic exposed deep deficiencies in our ability to detect, prevent, and respond to global health threats. FasterCures has sought to bring together global health leaders and experts to advance a vision for a coordinated global early warning system to address a key gap in current global disease surveillance efforts.
Cancer is the leading cause of death worldwide. Recent technological advancements in the field of cancer, such as the emergence of multi-cancer early detection tests, have the potential to change not only cancer care but also the areas in which research is conducted in the future.
FasterCures seeks to amplify new approaches and developments affecting the field of oncology and address barriers to their innovation.
Cell and gene therapies are transforming how we can treat and potentially cure disease. In response to a rapidly growing pipeline and the hope these therapies offer, FasterCures convenes roundtables and discussions to bring to light the unique regulatory and access considerations posed by cell and gene therapies.
The underrepresentation of diverse groups in clinical research, mistrust in research, and the lack of diversity in the health workforce play significant roles in the persistence of health inequities. FasterCures aims to develop strategies and policies to increase diversity and inclusion in all stages of clinical research and to change the culture of systems within the biomedical research community to value diversity and representation in the development and execution of clinical trials.
The FasterCures LeadersLink Program is a capacity-building program to support the personal development of an emerging cadre of leaders of nonprofit organizations that fund or conduct biomedical research. LeadersLink focuses on building participants’ leadership skills and professional network and addressing their top priorities through mentorship, a capstone project, a series of convenings, virtual collaboration, and access to Milken Institute events and networks.
We explore the root causes of health disparities that drive poorer health outcomes, and health policy to advance health equity for all.
Building thriving communities and advancing health equity require improving the interrelated social and economic conditions at the root causes of health outcomes. This includes ensuring that health communication, access, and delivery reflect the needs, experiences, and unique characteristics of historically excluded people.
Prevention and Chronic Disease is an all-encompassing priority that addresses how chronic diseases are understood and managed, how populations are impacted, and how issues related to infrastructure and financing can affect health and well-being.
Our Public Health initiative aims to improve health outcomes through research, programs, and policy initiatives with health equity as a central tenet. Following a public health approach, we engage with partners across sectors to raise awareness, propel action, and envision and pursue practical solutions toward measurable progress for complex health issues.
In order to attain total health, we must normalize a “whole person” approach that prioritizes mental and physical health equally. To do so, we are working strategically with employers, as they are uniquely positioned to reach employees, their families, and the surrounding communities, and can help them access evidence-based, innovative, inclusive prevention, treatment, and recovery resources to address mental health issues and addiction.
The three focus areas for our mental health work are 1) access to mental health services and resources, 2) innovation in scalable health technologies, and 3) investment in policy change (includes employers’ internal policies).
In our signature program, the Alliance to Improve Dementia Care, we bring together a multi-sector coalition of leaders to uncover the latest breakthroughs in brain health and we work to increase timely detection, improve access to treatment, coordinated care, and address health equity for people at risk for or living with dementia and their caregivers. Through expert workgroups, convenings, collaborative initiatives, and thought leadership, the Alliance amplifies and promotes the adoption of proven polices, solutions, and promising innovations in dementia care.
